Uveitis Treatment Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-04-06　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 906 Mn
2033 年預估規模: USD 1,389 Mn
年複合成長率 CAGR: 6.3%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-04-06頁數 152報告編號 CMI1094

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Uveitis Treatment Market, By Treatment Type (Corticosteroids, Immunosuppressant, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), By Disease type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, Pan uveitis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

報告摘要

Uveitis refers to inflammation caused in the uvea of the eye. A uvea is the middle layer of the eye that consists of three components namely iris, cilliary body, and the choroid. Uveitis is caused by various factors such as inflammatory diseases, injuries in the eye, microbial infections such as viral, bacterial, and fungal infection or exposure to certain toxic chemicals such as strong acids or pesticides. However, in many cases the cause of this condition remains unknown. It is also found to be effecting people belonging to the age group of 20–50 years. The condition is classified based on the location of inflammation in the uvea and is categorized in three types including anterior uveitis that causes inflammation in the iris and is the most commonly encountered type. Market Dynamics Increasing product launches by market players is expected to drive the global uveitis treatment market over the forecast period. For instance, in February 7, 2022, Alimera Sciences which is a biopharmaceutical company based in Georgia that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals, has announced that it has announced Launch of ILUVIEN (fluocinolone acetonide intravitreal implant) for Uveitis in Spain. ILUVIEN is a sustained release intravitreal implant approved for use in Europe to treat vision loss brought on by chronic diabetic macular edema (DME), which is thought to be under responsive to current treatments, as well as to prevent relapse in cases of recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU). ILUVIEN is made to deliver sub-microgram quantities of the corticosteroid fluocinolone acetonide for 36 months, which helps patients preserve their vision for longer between treatments. Key features of the study • This report provides in-depth analysis of the global uveitis treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global uveitis treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include AbbVie, Novartis AG, Bausch Health Companies Inc., Galapagos NV, EyePoint Pharmaceuticals, Inc., Clearside Biomedical, Tarsier Pharma Ltd, Santen Pharmaceutical Co., Ltd., Bausch & Lomb Incorporated, Sanofi and Regeneron Pharmaceuticals, Inc., Alimera Sciences • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global uveitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global uveitis treatment market Market Segmentation • By Treatment Type Insights (Revenue, USD Mn, 2021 - 2033) o Corticosteroids o Immunosuppressant o Monoclonal Antibodies o Cycloplegic Agents o Antibiotics o Antivirals o Antifungal o Analgesics • By Disease Type Insights (Revenue, USD Mn, 2021 - 2033) o Anterior Uveitis o Posterior Uveitis o Intermediate Uveitis o Pan uveitis • By Distribution Channel (Revenue, USD Mn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies o Drug Stores • By Region Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific  Middle East & Africa  GCC Countries  Israel  Rest of Middle East & Africa • Key Players in the Uveitis Treatment Market o AbbVie o Novartis AG o Bausch Health Companies Inc. o Galapagos NV o EyePoint Pharmaceuticals, Inc. o Clearside Biomedical o Tarsier Pharma Ltd o Santen Pharmaceutical Co., Ltd. o Bausch & Lomb Incorporated o Sanofi o Regeneron Pharmaceuticals o Alimera Sciences

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Treatment Type  Market Snapshot, By Disease Type  Market Snapshot, By Distribution Channel  Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o Recent Developments o Acquisitions and Partnerships Scenario o Technology Overview o Regulatory Scenario o Pipeline Analysis o PEST Analysis 4. Global Uveitis Treatment Market, By Treatment Type, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Corticosteroids  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Immunosuppressant  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Monoclonal Antibodies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Cycloplegic Agents  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Antibiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Antivirals  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Antifungal  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Antibiotics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Analgesics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 5. Global Uveitis Treatment Market, By Disease Type, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Anterior Uveitis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Posterior Uveitis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Intermediate Uveitis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Pan uveitis  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 6. Global Uveitis Treatment Market, By Distribution Channel, 2021 – 2033, (USD Mn) o Overview  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2021 – 2033  Segment Trends o Hospital Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Retail Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Online Pharmacies  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) o Drug Stores  Overview  Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 7. Global Uveitis Treatment Market, By Region, 2021 – 2033, (USD Mn) o Introduction  Market Share Analysis, By Region, 2026 and 2033 (%)  Y-o-Y Growth Analysis, For Regions, 2021–2033  Regional Trends o North America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o Brazil o Mexico o Argentina o Rest of Latin America o Europe  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn) o GCC o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)  Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Mn) o North Africa o Central Africa o South Africa 8. Competitive Landscape o AbbVie  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Bausch Health Companies Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Galapagos NV  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o EyePoint Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Clearside Biomedical  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Tarsier Pharma Ltd  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Santen Pharmaceutical Co., Ltd.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Bausch & Lomb Incorporated  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Sanofi  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Regeneron Pharmaceuticals, Inc.  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies o Alimera Sciences  Company Highlights  Product Portfolio  Key Highlights  Financial Performance  Market Strategies 9. Section o Research Methodology o About Us

提及公司

AbbVieNovartis AGBausch Health Companies Inc.Galapagos NVEyePoint Pharmaceuticals, Inc.Clearside BiomedicalTarsier Pharma LtdSanten Pharmaceutical Co., Ltd.Bausch & Lomb IncorporatedSanofiRegeneron PharmaceuticalsAlimera Sciences

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們